These findings suggest that the balance between DNA methyltransferase DNMT3a and demethylase TET1 determines the level of DNA demethylation in the RSPO3 promoter, which in turn affects the progression of CCA. The gene discussed is MBD2; the disease is cholangiocarcinoma.